Literature DB >> 1632690

Does preoperative radiation therapy enhance the probability of local control and survival in high-risk distal rectal cancer?

W M Mendenhall1, K I Bland, E M Copeland, G E Summers, W W Pfaff, W W Souba, R R Million.   

Abstract

One hundred forty-eight patients were treated with preoperative radiation therapy and surgery for resectable rectal adenocarcinoma at the University of Florida between 1975 and 1986. All patients had at least 5 years' follow-up; no patient was lost to follow-up. Three treatment protocols were used over the study period: 1975 to 1978, 3500 cGy in 20 fractions; 1979 to 1983, 4000 to 5000 cGy at 180 cGy per fraction; and 1984 to 1986, 3000 cGy in 10 fractions. The change was made to 3000 cGy in 10 fractions to reduce the inconvenience and expense associated with preoperative radiation therapy without sacrificing any improvement in local control or complication rates. There were no significant differences in the rates of local control, absolute survival, cause-specific survival, or complications between the three preoperative radiation therapy protocols. The results were compared for the 132 patients who underwent complete resection after preoperative radiation therapy and a series of 135 patients who underwent a complete resection alone for adenocarcinoma of the rectum at the University of Florida between 1959 and 1976. The results at 5 years, calculated by the product-limit method, for preoperative radiation therapy and surgery compared with surgery alone, respectively, were as follows: for local recurrence-free survival, 96% and 67%; for absolute survival, 66% and 40%; and for cause-specific survival, 77% and 50%. All of these differences are significant (p = 0.0001 or less). A subset of 56 patients with locally advanced lesions, based on tethering or circumferential involvement of the rectal lumen, treated with preoperative radiation therapy and surgery were compared with patients treated with surgery alone for stage B2 and C cancers. There was a significant improvement in local control and survival rates in the group irradiated before operation. There was no apparent increase in the incidence of postoperative complications in the patients irradiated before operation.

Entities:  

Mesh:

Year:  1992        PMID: 1632690      PMCID: PMC1242533          DOI: 10.1097/00000658-199206000-00017

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  33 in total

1.  Preoperative irradiation for carcinoma of the rectum and rectosigmoid colon: reportof a National Veterans Administration randomized study.

Authors:  B Roswit; G A Higgins; R J Keehn
Journal:  Cancer       Date:  1975-06       Impact factor: 6.860

2.  The prognostic significance of direct extension of carcinoma of the colon and rectum.

Authors:  V B ASTLER; F A COLLER
Journal:  Ann Surg       Date:  1954-06       Impact factor: 12.969

3.  Preoperative radiotherapy in operable rectal cancer.

Authors:  A Horn; J F Halvorsen; O Dahl
Journal:  Dis Colon Rectum       Date:  1990-10       Impact factor: 4.585

4.  Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC).

Authors:  A Gérard; M Buyse; B Nordlinger; J Loygue; F Pène; P Kempf; J F Bosset; M Gignoux; J P Arnaud; C Desaive
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

5.  Clinically resectable adenocarcinoma of the rectum treated with preoperative irradiation and surgery.

Authors:  W M Mendenhall; K I Bland; W R Rout; W W Pfaff; R R Million; E M Copeland
Journal:  Dis Colon Rectum       Date:  1988-04       Impact factor: 4.585

6.  T2 oral tongue carcinoma treated with radiotherapy: analysis of local control and complications.

Authors:  W M Mendenhall; J T Parsons; S P Stringer; N J Cassisi; R R Million
Journal:  Radiother Oncol       Date:  1989-12       Impact factor: 6.280

7.  A comparison of nonoperative vs. preoperative radiotherapy in rectal carcinoma. A 10-year randomized trial.

Authors:  J A Reis Neto; F A Quilici; J A Reis
Journal:  Dis Colon Rectum       Date:  1989-08       Impact factor: 4.585

8.  Patterns of failure following local excision and local excision and postoperative radiation therapy for invasive rectal adenocarcinoma.

Authors:  C G Willett; J E Tepper; S Donnelly; W C Wood; P C Shellito; G V Rodkey; M A Stracher; C C Compton
Journal:  J Clin Oncol       Date:  1989-08       Impact factor: 44.544

9.  Prolongation of the disease-free interval in surgically treated rectal carcinoma.

Authors: 
Journal:  N Engl J Med       Date:  1985-06-06       Impact factor: 91.245

10.  Postoperative adjuvant therapy of rectal cancer: an analysis of disease control, survival, and prognostic factors.

Authors:  S E Schild; J A Martenson; L L Gunderson; D M Ilstrup; K K Berg; M J O'Connell; L H Weiland
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-07       Impact factor: 7.038

View more
  9 in total

Review 1.  Non-operative management of rectal cancer: understanding tumor biology.

Authors:  Iris H Wei; Julio Garcia-Aguilar
Journal:  Minerva Chir       Date:  2018-05-24       Impact factor: 1.000

2.  Recent advances in the treatment and outcome of locally advanced rectal cancer.

Authors:  J N Vauthey; R W Marsh; R A Zlotecki; E K Abdalla; C C Solorzano; E J Bray; M E Freeman; G Y Lauwers; P S Kubilis; W M Mendenhall; E M Copeland
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969

3.  Preoperative adjuvant radiation with chemotherapy for rectal cancer: its impact on stage of disease and the role of endorectal ultrasound.

Authors:  A Bernini; K I Deen; R D Madoff; W D Wong
Journal:  Ann Surg Oncol       Date:  1996-03       Impact factor: 5.344

4.  Preoperative chemoradiotherapy in the management of localized rectal cancer: the new standard.

Authors:  Theodore S Hong; Lisa A Kachnic
Journal:  Gastrointest Cancer Res       Date:  2007-03

5.  Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumour stage and patient survival.

Authors:  D Ofner; H Maier; B Riedmann; T Bammer; A Rumer; G Winde; W Böcker; B Jasani; K W Schmid
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 6.  Sphincter preservation in rectal cancer.

Authors:  C G Willett
Journal:  Curr Treat Options Oncol       Date:  2000-12

7.  Adjuvant chemoradiation for localized rectal cancer: current trends and future directions.

Authors:  Lisa A Kachnic
Journal:  Gastrointest Cancer Res       Date:  2007

Review 8.  [Adjuvant and neoadjuvant therapy of rectal carcinoma. The current status].

Authors:  C Rödel; W Hohenberger; R Sauer
Journal:  Strahlenther Onkol       Date:  1998-10       Impact factor: 3.621

9.  Induction of VX2 para-renal carcinoma in rabbits: generation of animal model for loco-regional treatments of solid tumors.

Authors:  Sabrina Bimonte; Maddalena Leongito; Mauro Piccirillo; Maria Luisa Tamma; Marianna Vallifuoco; Adele Bracco; Antonio Mancini; Daniele Di Napoli; Sigismondo Castaldo; Santolo Cozzolino; Francesca Iacobellis; Roberto Grassi; Vincenza Granata; Secondo Lastoria; Steven Curley; Francesco Izzo
Journal:  Infect Agent Cancer       Date:  2016-12-01       Impact factor: 2.965

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.